Related Experiment Video
Updated: Jun 2, 2026

Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
Identification of a novel inhibitor of the canonical Wnt pathway
Kyoungmin Park1, Kyungwon Lee, Bin Zhang
1Department of Physiology, Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, usa.
Abstract:
Wnt signaling is known to regulate multiple processes including angiogenesis, inflammation, and fibrosis. Here, we identified a novel inhibitor of the Wnt pathway, pigment epithelium-derived factor (PEDF), a multifunctional serine proteinase inhibitor. Both overexpression of PEDF in transgenic mice and administration of PEDF protein attenuated Wnt signaling induced by retinal ischemia. Furthermore, PEDF knockdown by small interfering RNA (siRNA) and PEDF knockout in PEDF(-/-) mice induced activation of Wnt signaling. PEDF bound to LRP6, a Wnt coreceptor, with high affinity (K(d) [dissociation constant] of 3.7 nM) and blocked the Wnt signaling induced by Wnt ligand. The physical interaction of PEDF with LRP6 was confirmed by a coprecipitation assay, which showed that PEDF bound to LRP6 at the E1E2 domain. In addition, binding of PEDF to LRP6 blocked Wnt ligand-induced LRP6-Frizzled receptor dimerization, an essential step in Wnt signaling. These results suggest that PEDF is an endogenous antagonist of LRP6, and blocking Wnt signaling may represent a novel mechanism for its protective effects against diabetic retinopathy.
Insights
Pigment epithelium-derived factor (PEDF) inhibits Wnt signaling by binding to LRP6, blocking downstream effects. This discovery reveals a new mechanism for PEDF
Area of Science:
- Molecular Biology
- Cell Signaling
- Ophthalmology
Background:
- Wnt signaling regulates key cellular processes like angiogenesis and fibrosis.
- Diabetic retinopathy involves complex pathological pathways.
Purpose of the Study:
- To identify novel regulators of the Wnt pathway.
- To investigate the role of pigment epithelium-derived factor (PEDF) in Wnt signaling and its potential therapeutic implications.
Main Methods:
- Overexpression and knockdown studies of PEDF in transgenic mice and cell cultures.
- Small interfering RNA (siRNA) mediated knockdown and knockout mouse models.
- Biochemical assays including co-precipitation to confirm protein interactions.
- Analysis of Wnt signaling activation and inhibition.
Main Results:
- Pigment epithelium-derived factor (PEDF) was identified as a novel inhibitor of the Wnt pathway.
- PEDF directly binds to the Wnt coreceptor LRP6 with high affinity.
- PEDF binding prevents LRP6-Frizzled receptor dimerization, thereby blocking Wnt ligand-induced signaling.
- PEDF administration or overexpression attenuated Wnt signaling, while PEDF deficiency activated it.
Conclusions:
- Pigment epithelium-derived factor (PEDF) acts as an endogenous antagonist of LRP6.
- Blocking Wnt signaling via PEDF represents a potential therapeutic strategy for conditions like diabetic retinopathy.
More Related Videos
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Inhibition of Cdk Activity
Inhibition of CDK Activity
